CRSP
Price
$41.38
Change
-$1.96 (-4.52%)
Updated
Mar 11, 01:57 PM (EDT)
Capitalization
3.91B
62 days until earnings call
PLRX
Price
$1.51
Change
+$0.08 (+5.59%)
Updated
Mar 11, 03:08 PM (EDT)
Capitalization
87.26M
62 days until earnings call
Ad is loading...

CRSP vs PLRX

Header iconCRSP vs PLRX Comparison
Open Charts CRSP vs PLRXBanner chart's image
CRISPR Therapeutics AG
Price$41.38
Change-$1.96 (-4.52%)
Volume$6.91K
Capitalization3.91B
Pliant Therapeutics
Price$1.51
Change+$0.08 (+5.59%)
Volume$1.1K
Capitalization87.26M
CRSP vs PLRX Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. PLRX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and PLRX is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (CRSP: $43.34 vs. PLRX: $1.42)
Brand notoriety: CRSP and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 126% vs. PLRX: 69%
Market capitalization -- CRSP: $3.91B vs. PLRX: $87.26M
CRSP [@Biotechnology] is valued at $3.91B. PLRX’s [@Biotechnology] market capitalization is $87.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRSP and PLRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while PLRX’s TA Score has 5 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 5 bearish.
  • PLRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а +2.48% price change this week, while PLRX (@Biotechnology) price change was +3.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.68%. For the same industry, the average monthly price growth was -9.30%, and the average quarterly price growth was -8.75%.

Reported Earning Dates

CRSP is expected to report earnings on May 12, 2025.

PLRX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.91B) has a higher market cap than PLRX($87.3M). CRSP YTD gains are higher at: 10.112 vs. PLRX (-89.180). PLRX has higher annual earnings (EBITDA): -197.04M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. PLRX (405M). PLRX has less debt than CRSP: PLRX (60.2M) vs CRSP (228M). CRSP has higher revenues than PLRX: CRSP (200M) vs PLRX (0).
CRSPPLRXCRSP / PLRX
Capitalization3.91B87.3M4,473%
EBITDA-313.08M-197.04M159%
Gain YTD10.112-89.180-11%
P/E RatioN/AN/A-
Revenue200M0-
Total Cash1.94B405M478%
Total Debt228M60.2M379%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPPLRX
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
84%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIOTX22.61N/A
N/A
Pioneer Core Equity A
TEGRX26.90N/A
N/A
Templeton Growth R
CDGRX11.94N/A
N/A
Copeland Dividend Growth Fund Class A
GPTUX13.01N/A
N/A
GuidePath® Tactical Allocation Svc
SCURX29.75N/A
N/A
Hartford Schroders US Small Cap Opps SDR

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-4.81%
BEAM - CRSP
72%
Closely correlated
-9.80%
RXRX - CRSP
65%
Loosely correlated
-7.06%
PRME - CRSP
64%
Loosely correlated
-13.33%
NTLA - CRSP
61%
Loosely correlated
-8.60%
ALLO - CRSP
58%
Loosely correlated
-6.19%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-12.04%
LXRX - PLRX
44%
Loosely correlated
-8.17%
ITRM - PLRX
41%
Loosely correlated
-5.43%
SRRK - PLRX
41%
Loosely correlated
-2.31%
FHTX - PLRX
40%
Loosely correlated
-2.65%
CRGX - PLRX
37%
Loosely correlated
+1.26%
More